David Cohen
Affiliations: | Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States |
Area:
BiomagnetismWebsite:
http://www.nmr.mgh.harvard.edu/martinos/people/showPerson.php?people_id=33Google:
"David Cohen"Mean distance: 16.13 (cluster 29)
Children
Sign in to add traineeJennifer R. Melcher | grad student | MIT | |
Baran A. Ersoy | post-doc | Massachusetts General Hospital and Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kabbani M, Michailidis E, Steensels S, et al. (2022) Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice. Cell Reports. 40: 111321 |
Ersoy BA, Maner-Smith KM, Li Y, et al. (2017) Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress. The Journal of Clinical Investigation |
Kawano Y, Ersoy BA, Li Y, et al. (2014) Thioesterase superfamily member 2 (Them2) and phosphatidylcholine transfer protein (PC-TP) interact to promote fatty acid oxidation and control glucose utilization. Molecular and Cellular Biology. 34: 2396-408 |
Ersoy BA, Tarun A, D'Aquino K, et al. (2013) Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling. Science Signaling. 6: ra64 |
Shishova EY, Stoll JM, Ersoy BA, et al. (2011) Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology (Baltimore, Md.). 54: 664-74 |